The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Chon HS, Marchion DC, Xiong Y, Chen N, Bicaku E, Stickles XB, Bou Zgheib N, Judson PL, Hakam A, Gonzalez-Bosquet J, Wenham RM, Apte SM, Lancaster JM.
Chon HS, et al. Among authors: marchion dc.
Gynecol Oncol. 2012 Jan;124(1):119-24. doi: 10.1016/j.ygyno.2011.09.020. Epub 2011 Oct 26.
Gynecol Oncol. 2012.
PMID: 22032837
Free PMC article.